ArticleDiagnostics (Basel, Switzerland)2024
An Empirical Evaluation of a Novel Ensemble Deep Neural Network Model and Explainable AI for Accurate Segmentation and Classification of Ovarian Tumors Using CT Images.
Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Diagnostic accuracy of ovarian cancer using convolutional neural network: a systematic review and meta-analysis.BMC medical informatics and decision making · 2026Pooled it
- Deep neural architecture empowered by explainable artificial intelligence for accurate and early diagnosis of gynaecological cancer using medical images.Scientific reports · 2026Article
- Hybrid I-ResNeT-ViT and Cost-Sensitive InceptionV3 Models for Tumour Severity and Malignancy Classification Using Medical Imaging.Asian Pacific journal of cancer prevention : APJCP · 2026Article
- Artificial intelligence for precision oncology from phenotyping and drug discovery to clinical translation.Discover oncology · 2026Review
- Evaluating Performance of a Deep Learning-based Artificial Intelligence Model for Ovarian Tumor Classification Using a Multicenter CT Dataset.Radiology. Imaging cancer · 2026Article
- Artificial intelligence (AI) and machine learning (ML) in ovarian cancer: transforming detection, treatment, and prevention.Journal of ovarian research · 2026Review
- Deep learning accurately and reliably segments pelvic vascular structure in CT scans of gynecologic cancer patients.Frontiers in oncology · 2026Article
- Multiple perception contrastive learning for automated ovarian tumor classification in CT images.Abdominal radiology (New York) · 2025Article
- Enhancing lane detection in autonomous vehicles with multi-armed bandit ensemble learning.Scientific reports · 2025Article
- Automatic segmentation model and machine learning model grounded in ultrasound radiomics for distinguishing between low malignant risk and intermediate-high malignant risk of adnexal masses.Insights into imaging · 2025Article
- Prospects and challenges of deep learning in gynecologic malignancies.Frontiers in oncology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian cancer is one of the leading causes of death worldwide among the female population. Early diagnosis is crucial for patient treatment. In this work, our main objective is to accurately detect and classify ovarian cancer. To achieve this, two datasets are considered: CT scan images of patients with cancer and those without, and biomarker (clinical parameters) data from all patients. We propose an ensemble deep neural network model and an ensemble machine learning model for the automatic binary classification of ovarian CT scan images and biomarker data. The proposed model incorporates four convolutional neural network models: VGG16, ResNet 152, Inception V3, and DenseNet 101, with transformers applied for feature extraction. These extracted features are fed into our proposed ensemble multi-layer perceptron model for classification. Preprocessing and CNN tuning techniques such as hyperparameter optimization, data augmentation, and fine-tuning are utilized during model training. Our ensemble model outperforms single classifiers and machine learning algorithms, achieving a mean accuracy of 98.96%, a precision of 97.44%, and an F1-score of 98.7%. We compared these results with those obtained using features extracted by the UNet model, followed by classification with our ensemble model. The transformer demonstrated superior performance in feature extraction over the UNet, with a mean Dice score and mean Jaccard score of 0.98 and 0.97, respectively, and standard deviations of 0.04 and 0.06 for benign tumors and 0.99 and 0.98 with standard deviations of 0.01 for malignant tumors. For the biomarker data, the combination of five machine learning models-KNN, logistic regression, SVM, decision tree, and random forest-resulted in an improved accuracy of 92.8% compared to single classifiers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.